A Study to Evaluate IGSC 20% Biweekly Dosing in Treatment-Experienced Participants and Loading/Maintenance Dosing in Treatment-Naïve Participants With Primary Immunodeficiency
Clinical trial NCT04566692 · COMPLETED
Trial details
- NCT number
- NCT04566692
- Sponsor
- Grifols Therapeutics LLC
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-24
- Primary completion
- 2022-07-18
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.